Tag: regulatory science

Operationalizing RWD Privacy, Consent & Governance Across Global Programs The integration of Real-World Data (RWD) into clinical trials presents a significant opportunity to enhance research outcomes, particularly in fields such as oncology and psychiatry. This tutorial provides a comprehensive guide for clinical operations, regulatory affairs, and medical affairs professionals on operationalizing RWD privacy, consent, and…

Read More “Operationalizing RWD Privacy, Consent & Governance Across Global Programs” »

How AI and Automation Are Transforming RWD Privacy, Consent & Governance The landscape of clinical trials has been evolving rapidly, primarily due to the emergence of Real-World Data (RWD) and the increasing reliance on technological advancements such as Artificial Intelligence (AI) and automation. These tools are revolutionizing how organizations manage privacy, consent, and governance in…

Read More “How AI and Automation Are Transforming RWD Privacy, Consent & Governance” »

Future Trends: Real-World, Digital and Hybrid Evidence in RWD Privacy, Consent & Governance Future Trends: Real-World, Digital and Hybrid Evidence in RWD Privacy, Consent & Governance The landscape of clinical research is shifting towards the incorporation of real-world data (RWD), digital methodologies, and hybrid models of evidence generation. This evolution is pertinent in both regulatory…

Read More “Future Trends: Real-World, Digital and Hybrid Evidence in RWD Privacy, Consent & Governance” »

Digital Tools and Data Pipelines to Strengthen RWD Privacy, Consent & Governance Digital Tools and Data Pipelines to Strengthen RWD Privacy, Consent & Governance In the landscape of clinical research, ensuring the privacy and consent of real-world data (RWD) subjects is paramount. This detailed guide aims to elucidate how digital tools and data pipelines can…

Read More “Digital Tools and Data Pipelines to Strengthen RWD Privacy, Consent & Governance” »

KRIs, KPIs and Quality Metrics to Improve RWD Privacy, Consent & Governance KRIs, KPIs and Quality Metrics to Improve RWD Privacy, Consent & Governance Introduction to Real-World Data (RWD) and Its Impact on Clinical Trials Real-world data (RWD) has emerged as a critical component in the arsenal of clinical research and healthcare decision-making. RWD refers…

Read More “KRIs, KPIs and Quality Metrics to Improve RWD Privacy, Consent & Governance” »

Case Studies: RWD Privacy, Consent & Governance That Changed Regulatory or Payer Decisions Case Studies: RWD Privacy, Consent & Governance That Changed Regulatory or Payer Decisions The landscape of clinical trials is evolving, particularly with the focus on real-world evidence (RWE) and its implications for regulatory decisions and payer policies. This tutorial will delve into…

Read More “Case Studies: RWD Privacy, Consent & Governance That Changed Regulatory or Payer Decisions” »

Integrating RWD Privacy, Consent & Governance With Clinical Trials, RCTs and Hybrid Designs Integrating RWD Privacy, Consent & Governance With Clinical Trials, RCTs and Hybrid Designs The integration of Real-World Data (RWD) into clinical trial solutions is becoming increasingly significant, as regulatory authorities such as the FDA, EMA, and MHRA acknowledge its value to enhance…

Read More “Integrating RWD Privacy, Consent & Governance With Clinical Trials, RCTs and Hybrid Designs” »

Data Models, Standards and Metadata Needed for Strong RWD Privacy, Consent & Governance As clinical trials increasingly integrate real-world data (RWD) and evidence (RWE) into their design and execution, ensuring robust privacy, consent, and governance frameworks is paramount. This article provides a comprehensive, step-by-step guide tailored for professionals in clinical operations, regulatory affairs, and medical…

Read More “Data Models, Standards and Metadata Needed for Strong RWD Privacy, Consent & Governance” »

RWD Privacy, Consent & Governance: Best Practices for High-Validity Real-World Evidence In the evolving landscape of clinical research, the application of Real-World Data (RWD) and Real-World Evidence (RWE) has become pivotal, particularly in the context of ankylosing spondylitis clinical trials. These methodologies provide researchers and clinicians with the necessary insights to enhance patient care and…

Read More “RWD Privacy, Consent & Governance: Best Practices for High-Validity Real-World Evidence” »

How to Design RWD Privacy, Consent & Governance for FDA, EMA and HTA Acceptance In the era of digital health and innovative therapeutic options, the use of Real-World Data (RWD) is becoming crucial in clinical research. Designing effective privacy, consent, and governance systems for RWD is paramount for ensuring compliance with relevant regulations enforced by…

Read More “How to Design RWD Privacy, Consent & Governance for FDA, EMA and HTA Acceptance” »